未分類

[口試公告] 112-2碩士學位論文口試

 

學生姓名 口試時間 論文題目
鄭詠馨
TA, YONG XIN
2024/07/12 蒲公英狀奈米載體結合具標靶性適配體以達到胰臟癌化學免疫療法的效果
Dandelion-like nanoparticles with aptamer-targeted function for chemoimmunotherapeutic strategies in pancreatic cancer
易恩頡
YI, EN-CHIEH
2024/07/10 偏頭痛病人血球數值及頭痛嚴重程度和預防性用藥評估探討 
Evaluation of the Correlation in Hematological Parameters, Severity of Migraine and Effectiveness of Migraine Prophylactic Therapies
廖旭晨
LIAO, HSU-CHEN
2024/07/05 非小細胞肺癌患者使用ALK抑制劑所致心毒性之風險探討
Investigation of the Risk of Cardiotoxicity Associated with ALK Inhibitors in Non-Small Cell Lung Cancer Patients
蘇庭弘
SU, TING-HONG
2024/07/04 桂花之化學成分及生物活性之研究 
Studies on the Main Chemical Constituents and Biological Activities of the Flowers of Osmanthus fragrans
張育瑄
CHANG, YU-HSUAN
2024/07/04 台灣產桑椹之化學成分及生物活性之研究
Studies on the Main Chemical Components and their Biological Activities of the Fruits of Taiwanese Morus alba L.
詹子寬
CHAN, TZU-KUAN
2024/07/03 SGLT2抑制劑與GLP-1受體促效劑用於糖尿病病人心肌梗塞後預後之影響
The Clinical Benefits of SGLT2i and GLP-1RA on Post-myocardial Infarction in Diabetic Patients
李柏宏
LEE, PO HUNG
2024/6/27 以台灣醫師、法規管理與健康保險人員及學者專家之觀點探討生物相似性藥品可交換使用管理方式之態度
Attitudes toward approaches to interchangeability of biosimilars: Perspectives from prescribers, regulators, and experts in Taiwan
詹書華
CHAN, SHU-HUA
2024/6/13 台灣擴散期小細胞肺癌病人使用第一線療法免疫檢查點抑制劑Durvalumab或Atezolizumab合併化學治療或單用化學治療之成本效果分析
Cost-Effectiveness Analysis of Durvalumab and Atezolizumab Immunochemotherapies Versus Chemotherapy Alone as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer in Taiwan
魏婕安
WEI, CHIEH-AN
2024/6/11 從實驗室內部的小分子化合物資料庫中探索用於治療癌症的潛在候選藥物
Exploring the potential drug candidates from in-house small molecules compound library for cancer treatment

 

~ 2024/6/13更新